Trials / Terminated
TerminatedNCT01117376
Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients
Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients Intolerant to Enteral Feeding
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
42 patients admitted in ICU with intolerance to enteral feeding (GRV more than 250 ml) are recruited. All patients enter a primary acetaminophen absorption test study as baseline. Serum levels of acetaminophen will be measured by florescence polarization method at 15,30,45,60,90,120,180,240,480 minutes after enteral administration of 975 mg acetaminophen. Then the patients will be randomized to methylnaltrexone or erythromycin group.Another acetaminophen absorption test with the same schedule will be done after the last dose of each drug.The area under the curve for acetaminophen blood level will be used to compare the effect of two studied drugs on gastric emptying time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erythromycin | Erythromycin 250 mg intravenous Q6h for 4 doses |
| DRUG | Methylnaltrexone | Methylnaltrexone 12 mg subcutaneous Q12h for 2 doses |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-06-01
- Completion
- 2011-08-01
- First posted
- 2010-05-05
- Last updated
- 2011-03-31
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01117376. Inclusion in this directory is not an endorsement.